Back to Search
Start Over
Eagle Pharmaceuticals Initiates Rolling Submission of NDA for Ryanodex in Exertional Heat Stroke
- Source :
- Business Wire. November 11, 2016
- Publication Year :
- 2016
-
Abstract
- WOODCLIFF LAKE, N.J. -- Eagle Pharmaceuticals ('Eagle' or the 'Company') (NASDAQ: EGRX) today announced that the Company has initiated the rolling submission of its New Drug Application (NDA) and filed [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.469747705